WI
IDXG

WHV Investments’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

WHV Investments’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-454
Closed -$219K – 230
2013
Q3 		$219K Buy
454
+2
+0.4% +$958 ﹤0.01% 228
2013
Q2 		$212K Buy
+452
New +$205K ﹤0.01% 241

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LCM
Leonard Capital Management Vero Beach, Florida $5.25M AUM
SKK
Shepherd Kaplan Krochuk Boston, Massachusetts $119M AUM 8.32% 1-Year Est. Return

WHV Investments's IDXG Position: Q4 2013 in Review

WHV Investments sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q4 2013, closing a stake of 454 shares — an estimated $219K sold.

WHV Investments first reported a position in IDXG in Q2 2013 and held it in 2 quarters. The position peaked at $219K in Q3 2013. 26 funds tracked by Wall St. Rank hold IDXG as of Q4 2013.

  • WHV Investments reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • WHV Investments sold 454 Interpace Biosciences, Inc. Common Stock shares in Q4 2013, an estimated $219K.
  • WHV Investments first reported a position in Interpace Biosciences, Inc. Common Stock in Q2 2013 and held it in 2 quarters.
  • WHV Investments's Interpace Biosciences, Inc. Common Stock position peaked at $219K in Q3 2013.
  • 26 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q4 2013.

Based on WHV Investments's 13F filing for Q4 2013, filed 14 Feb 2014.